Breadcrumb Home Studies Studies Search Filter Research Area All Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPendingWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 128 studies. P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded P1065: Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth (Versions 1.0 - 3.0) and Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth (Version 4.0) DAIDS Number 10396 Research Area Other Study Status Concluded P1063: Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of Increased LDL-Cholesterol in HIV-Infected children, Adolescents, and Young Adults DAIDS Number 10167 Research Area Complications & Comorbidities Study Status Concluded P1061s: Evaluation of Immunologic Mememory in HIV-Infected Children Treated with HAART. DAIDS Number 10132 Research Area Other Study Status Concluded P1060: NNRTI-Based vs. PI-Based ART in Infants Exposed/Not Exposed to NVP for PMTCT DAIDS Number 10166 Research Area Treatment Study Status Concluded P1059: Phase I Trial of Recombinant Vaccines in HIV+ Young Adults DAIDS Number 10051 Research Area Other Study Status Concluded P1058A: Pharmacokinetics of New Classes of Antiretroviral Drug Combinations DAIDS Number 10809 Research Area Other Study Status Concluded P1057: Safety & Immunogenicity of Cold Adapted Influenza Vaccine In HIV-Infected Child DAIDS Number 10270 Research Area Other Study Status Concluded P1056: GPO-VIR PK Study DAIDS Number 10139 Research Area Other Study Status Concluded P1055: Psychiatric Co-Morbidity in Perinatally-Infected Children. DAIDS Number 10049 Research Area Other Study Status Concluded Pagination Previous page Prev Page 1 … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 Next page Next
P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded
P1065: Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth (Versions 1.0 - 3.0) and Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth (Version 4.0) DAIDS Number 10396 Research Area Other Study Status Concluded
P1063: Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of Increased LDL-Cholesterol in HIV-Infected children, Adolescents, and Young Adults DAIDS Number 10167 Research Area Complications & Comorbidities Study Status Concluded
P1061s: Evaluation of Immunologic Mememory in HIV-Infected Children Treated with HAART. DAIDS Number 10132 Research Area Other Study Status Concluded
P1060: NNRTI-Based vs. PI-Based ART in Infants Exposed/Not Exposed to NVP for PMTCT DAIDS Number 10166 Research Area Treatment Study Status Concluded
P1059: Phase I Trial of Recombinant Vaccines in HIV+ Young Adults DAIDS Number 10051 Research Area Other Study Status Concluded
P1058A: Pharmacokinetics of New Classes of Antiretroviral Drug Combinations DAIDS Number 10809 Research Area Other Study Status Concluded
P1057: Safety & Immunogenicity of Cold Adapted Influenza Vaccine In HIV-Infected Child DAIDS Number 10270 Research Area Other Study Status Concluded
P1055: Psychiatric Co-Morbidity in Perinatally-Infected Children. DAIDS Number 10049 Research Area Other Study Status Concluded
